Starling AJ, Cowan RP, Buse DC, Diener HC, et al. Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial. Headache 2023 Jan 12. doi: 10.1111/head.14434.
PMID: 36633219